{
    "2020-02-18": [
        [
            {
                "time": "",
                "original_text": "康泰生物：调整2019年度非公开发行股票方案",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "非公开发行",
                        "股票方案"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：3名高管合计减持23.87万股 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "高管",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：高级管理人员减持0.04%公司股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "高级管理人员",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：控股股东、实控人的一致行动人杜兴连拟减持不超30万股 拟减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "控股股东",
                        "实控人",
                        "一致行动人",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "20余企业角逐新冠疫苗研发 mRNA成焦点",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "研发",
                        "mRNA",
                        "企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}